A	O
92	O
-	O
year	O
-	O
old	B:C0025266
man	I:C0025266
with	O
primary	O
cutaneous	I:C1511566
diffuse	I:C1511566
large	I:C1511566
B	I:C1511566
-	I:C1511566
cell	I:C1511566
non-Hodgkin	I:C1511566
's	I:C1511566
lymphoma	I:C1511566
manifesting	O
as	O
a	O
giant	O
scalp	O
mass	I:C0577559
:	O
A	O
case	O
report	I:C0007320
.	O

A	O
92	O
-	O
year	O
-	O
old	O
man	I:C0025266
with	O
primary	B:C1511566
cutaneous	I:C1511566
diffuse	I:C1511566
large	I:C1511566
B	I:C1511566
-	I:C1511566
cell	I:C1511566
non-Hodgkin	I:C1511566
's	I:C1511566
lymphoma	I:C1511566
manifesting	O
as	O
a	O
giant	O
scalp	O
mass	I:C0577559
:	O
A	O
case	O
report	I:C0007320
.	O

A	O
92	O
-	O
year	O
-	O
old	O
man	I:C0025266
with	O
primary	O
cutaneous	I:C1511566
diffuse	I:C1511566
large	I:C1511566
B	I:C1511566
-	I:C1511566
cell	I:C1511566
non-Hodgkin	I:C1511566
's	I:C1511566
lymphoma	I:C1511566
manifesting	O
as	O
a	O
giant	O
scalp	B:C0577559
mass	I:C0577559
:	O
A	O
case	O
report	I:C0007320
.	O

A	O
92	O
-	O
year	O
-	O
old	O
man	I:C0025266
with	O
primary	O
cutaneous	I:C1511566
diffuse	I:C1511566
large	I:C1511566
B	I:C1511566
-	I:C1511566
cell	I:C1511566
non-Hodgkin	I:C1511566
's	I:C1511566
lymphoma	I:C1511566
manifesting	O
as	O
a	O
giant	O
scalp	O
mass	I:C0577559
:	O
A	O
case	B:C0007320
report	I:C0007320
.	O

Primary	B:C1511566
cutaneous	I:C1511566
non-Hodgkin's	I:C1511566
lymphoma	I:C1511566
(	O
non-Hodgkin's	O
lymphoma	I:C1511566
)	O
is	O
an	O
uncommon	O
entity	O
,	O
representing	O
10	O
%	O
of	O
all	O
extranodal	O
NHLs	O
.	O

Primary	O
cutaneous	I:C1511566
non-Hodgkin's	I:C1511566
lymphoma	I:C1511566
(	O
non-Hodgkin's	B:C1511566
lymphoma	I:C1511566
)	O
is	O
an	O
uncommon	O
entity	O
,	O
representing	O
10	O
%	O
of	O
all	O
extranodal	O
NHLs	O
.	O

Primary	O
cutaneous	I:C1511566
non-Hodgkin's	I:C1511566
lymphoma	I:C1511566
(	O
non-Hodgkin's	O
lymphoma	I:C1511566
)	O
is	O
an	O
uncommon	O
entity	O
,	O
representing	O
10	O
%	O
of	O
all	O
extranodal	B:C1517067
NHLs	O
.	O

Primary	O
cutaneous	I:C1511566
non-Hodgkin's	I:C1511566
lymphoma	I:C1511566
(	O
non-Hodgkin's	O
lymphoma	I:C1511566
)	O
is	O
an	O
uncommon	O
entity	O
,	O
representing	O
10	O
%	O
of	O
all	O
extranodal	O
NHLs	B:C0024305
.	O

Among	O
all	O
cutaneous	B:C0221912
sites	I:C0221912
,	O
the	O
scalp	O
is	O
a	O
rare	O
site	O
of	O
representation	O
.	O

Among	O
all	O
cutaneous	O
sites	I:C0221912
,	O
the	O
scalp	B:C0036270
is	O
a	O
rare	O
site	O
of	O
representation	O
.	O

Among	O
all	O
cutaneous	O
sites	I:C0221912
,	O
the	O
scalp	O
is	O
a	O
rare	O
site	B:C0005898
of	O
representation	O
.	O

A	O
92	O
-	O
year	O
-	O
old	O
Chinese	B:C0152035
man	O
visited	O
our	O
hospital	O
with	O
a	O
multiple	O
-	I:C0577559
nodular	I:C0577559
huge	I:C0577559
scalp	I:C0577559
mass	I:C0577559
on	O
the	O
right	O
parieto	I:C0005898
-	I:C0005898
occipital	I:C0005898
regions	I:C0005898
.	O

A	O
92	O
-	O
year	O
-	O
old	O
Chinese	O
man	O
visited	O
our	O
hospital	B:C0019994
with	O
a	O
multiple	O
-	I:C0577559
nodular	I:C0577559
huge	I:C0577559
scalp	I:C0577559
mass	I:C0577559
on	O
the	O
right	O
parieto	I:C0005898
-	I:C0005898
occipital	I:C0005898
regions	I:C0005898
.	O

A	O
92	O
-	O
year	O
-	O
old	O
Chinese	O
man	O
visited	O
our	O
hospital	O
with	O
a	O
multiple	B:C0577559
-	I:C0577559
nodular	I:C0577559
huge	I:C0577559
scalp	I:C0577559
mass	I:C0577559
on	O
the	O
right	O
parieto	I:C0005898
-	I:C0005898
occipital	I:C0005898
regions	I:C0005898
.	O

A	O
92	O
-	O
year	O
-	O
old	O
Chinese	O
man	O
visited	O
our	O
hospital	O
with	O
a	O
multiple	O
-	I:C0577559
nodular	I:C0577559
huge	I:C0577559
scalp	I:C0577559
mass	I:C0577559
on	O
the	O
right	B:C0005898
parieto	I:C0005898
-	I:C0005898
occipital	I:C0005898
regions	I:C0005898
.	O

The	O
mass	B:C0577559
was	O
of	O
7	O
-	O
month	O
duration	O
and	O
progressively	O
enlarging	O
in	O
size	O
.	O

The	O
mass	O
was	O
of	O
7	O
-	O
month	O
duration	O
and	O
progressively	O
enlarging	O
in	O
size	B:C0475440
.	O

On	O
the	O
basis	O
of	O
the	O
result	B:C0587081
of	O
biopsy	O
,	O
diffuse	O
large	I:C0079744
B	I:C0079744
-	I:C0079744
cell	I:C0079744
NHL	I:C0079744
was	O
diagnosed	O
.	O

On	O
the	O
basis	O
of	O
the	O
result	O
of	O
biopsy	B:C0005558
,	O
diffuse	O
large	I:C0079744
B	I:C0079744
-	I:C0079744
cell	I:C0079744
NHL	I:C0079744
was	O
diagnosed	O
.	O

On	O
the	O
basis	O
of	O
the	O
result	O
of	O
biopsy	O
,	O
diffuse	B:C0079744
large	I:C0079744
B	I:C0079744
-	I:C0079744
cell	I:C0079744
NHL	I:C0079744
was	O
diagnosed	O
.	O

On	O
the	O
basis	O
of	O
the	O
result	O
of	O
biopsy	O
,	O
diffuse	O
large	I:C0079744
B	I:C0079744
-	I:C0079744
cell	I:C0079744
NHL	I:C0079744
was	O
diagnosed	B:C0011900
.	O

The	O
mass	B:C0577559
was	O
partially	O
resected	O
by	O
surgery	O
and	O
no	O
further	O
treatment	O
was	O
conducted	O
due	O
to	O
the	O
advanced	O
age	O
and	O
poor	O
physical	O
status	O
.	O

The	O
mass	O
was	O
partially	O
resected	O
by	O
surgery	B:C0543467
and	O
no	O
further	O
treatment	O
was	O
conducted	O
due	O
to	O
the	O
advanced	O
age	O
and	O
poor	O
physical	O
status	O
.	O

The	O
mass	O
was	O
partially	O
resected	O
by	O
surgery	O
and	O
no	O
further	O
treatment	B:C0087111
was	O
conducted	O
due	O
to	O
the	O
advanced	O
age	O
and	O
poor	O
physical	O
status	O
.	O

The	O
tumor	B:C0027651
relapsed	O
in	O
situ	I:C0444498
after	O
6	O
months	O
and	O
the	O
patient	O
died	I:C0184772
after	O
2	O
years	O
.	O

The	O
tumor	O
relapsed	B:C0549379
in	O
situ	I:C0444498
after	O
6	O
months	O
and	O
the	O
patient	O
died	I:C0184772
after	O
2	O
years	O
.	O

The	O
tumor	O
relapsed	O
in	B:C0444498
situ	I:C0444498
after	O
6	O
months	O
and	O
the	O
patient	O
died	I:C0184772
after	O
2	O
years	O
.	O

The	O
tumor	O
relapsed	O
in	O
situ	I:C0444498
after	O
6	O
months	O
and	O
the	O
patient	B:C0184772
died	I:C0184772
after	O
2	O
years	O
.	O

This	O
case	O
highlighted	O
the	O
limited	O
access	O
to	O
standard	B:C0683525
treatment	I:C0683525
options	I:C0683525
in	O
patients	O
with	O
advanced	O
age	O
.	O

A	O
thorough	O
examination	B:C0582103
is	O
necessary	O
to	O
decide	O
upon	O
the	O
treatment	O
for	O
the	O
primary	O
cutaneous	I:C1302772
lymphoma	I:C1302772
.	O

A	O
thorough	O
examination	O
is	O
necessary	O
to	O
decide	O
upon	O
the	O
treatment	B:C0087111
for	O
the	O
primary	O
cutaneous	I:C1302772
lymphoma	I:C1302772
.	O

A	O
thorough	O
examination	O
is	O
necessary	O
to	O
decide	O
upon	O
the	O
treatment	O
for	O
the	O
primary	B:C1302772
cutaneous	I:C1302772
lymphoma	I:C1302772
.	O

